Core Laboratories Inc. /De/ (CLB) Stock Price & Analysis
Core Laboratories Inc. /De/ (CLB) fell 1.10% to USD 11.67 as of July 25, 2026 at 21:24 UTC, according to Nexqual real-time market data.
CLB last closed at USD 11.8; the session ranged USD 11.57–12.17 on volume of 640,561 shares. Market capitalization is $537.95M, with a 52-week range of USD 9.72–20.36 (NYQ). Source: Nexqual, July 25, 2026 at 21:24 UTC.
Key Statistics (as of July 25, 2026 at 21:24 UTC)
| Price | USD 11.67 |
|---|---|
| Change | ▼ 1.10% (down) |
| Previous Close | USD 11.8 |
| Open | USD 11.94 |
| Day Range | USD 11.57 – 12.17 |
| 52-Week Range | USD 9.72 – 20.36 |
| Volume | 640,561 shares |
| Market Cap | $537.95M |
| Exchange | NYQ |
Technical Analysis (CLB)
Nexqual's technical model rates CLB "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 21:24 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.47 (neutral) |
| vs SMA50 | Below (USD 12.39) |
| MACD | -0.19 (negative) |
Analyst Ratings (CLB)
Wall Street analysts rate CLB "Hold" based on 3 analysts, with a mean price target of USD 15.5 (range USD 11–22), per Nexqual as of July 25, 2026 at 21:24 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 15.5 |
| High Target | USD 22 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 1 / 1 / 1 |
Earnings (CLB)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.09 |
| Revenue Estimate | $125.10M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.06 vs est 0.11 ▼ miss |
| 2025-12-31 | USD 0.21 vs est 0.19 ▲ beat |
| 2025-09-30 | USD 0.22 vs est 0.19 ▲ beat |
| 2025-06-30 | USD 0.19 vs est 0.18 ▲ beat |
Source: Nexqual, July 25, 2026 at 21:24 UTC.
Financials & Fundamentals (CLB)
| Total Revenue | $524.73M |
|---|---|
| Revenue Growth (YoY) | -1.40% |
| Gross Margin | +19.92% |
| Operating Margin | +1.62% |
| Profit Margin | +5.53% |
| ROE | +11.06% |
| Debt / Equity | 61 |
| Current Ratio | 2.05 |
| Total Cash | $22.82M |
| Total Debt | $167.84M |
| Free Cash Flow | $44.22M |
Source: Nexqual, July 25, 2026 at 21:24 UTC.
Financial Health Score (CLB)
Nexqual rates Core Laboratories Inc. /De/'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 21:24 UTC.
| Growth | Mixed — Revenue +0.5% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 20%, operating 2% |
| Balance Sheet | Strong — $23M cash vs $168M debt |
| Cash Flow | Solid — FCF $44M, 8% margin |
| Efficiency | Mixed — ROE 11%, ROA 4.9% |
Ownership (CLB)
| Insider Ownership | +1.43% |
|---|---|
| Institutional Ownership | +113.81% |
| Shares Outstanding | 46.10M |
| Float | 45.45M |
| Short % of Float | +20.79% |
Source: Nexqual, July 25, 2026 at 21:24 UTC.
Leadership (CLB)
Core Laboratories Inc. /De/ is led by Lawrence V. Bruno (age 65), Chairman of the Board, CEO, President & COO, per Nexqual as of July 25, 2026 at 21:24 UTC.
| Chairman of the Board, CEO, President & COO | Lawrence V. Bruno (age 65) |
|---|---|
| Senior VP & CFO | Christopher Scott Hill (age 55) |
| Senior Vice President of Corporate Development & Investor Relations | Gwendolyn Y. Gresham (age 57) |
| Vice President of People, Organization & Culture | Leslie D. Linklater |
Major Backers & Investors (CLB)
Notable institutional backers of Core Laboratories Inc. /De/ include Ariel Investments, LLC, Ariel Investment Trust-Ariel Fund, Disciplined Growth Investors, Inc., according to Nexqual as of July 25, 2026 at 21:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Ariel Investments, LLC | 28.57% |
| Ariel Investment Trust-Ariel Fund | 15.02% |
| Disciplined Growth Investors, Inc. | 10.71% |
| Earnest Partners LLC | 6.63% |
| CWA Asset Management Group, LLC | 3.81% |
| HARBOR FUNDS-Harbor Small Cap Value Fund | 2.5% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.21% |
| Vanguard Group | 9.67% |
| State Street | 5.38% |
| Dimensional Fund Advisors | 2.93% |
Source: Nexqual, July 25, 2026 at 21:24 UTC.
From Core Laboratories Inc. /De/'s Latest SEC 10-K Filing (filed 2026-03-23)
Key Strengths & Strategy (as disclosed to the SEC)
- We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major, national and independent oil companies.
- While we have patented some of our key technologies, we do not patent all of our proprietary technology even where regarded as patentable.
- We also use our proprietary services and technologies to correlate the reservoir description data to wireline logs and other subsurface data.
- This global emphasis allows us to increase our revenue and enhance our profit through efficient utilization of our worldwide network.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OII | Oceaneering International, Inc. | USD 52.73 | ▲ 17.18% |
| FTI | TechnipFMC plc | USD 76.75 | ▲ 2.2% |
| RES | RPC, Inc. | USD 5.61 | ▼ 6.19% |
| OIS | Oil States International, Inc. | USD 8.67 | ▼ 0.69% |
| NOV | NOV Inc. | USD 20.76 | ▲ 2.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 21:24 UTC. This page is informational and not investment advice.